Efficacy
proven
in observational studies*

Braster offers a chance for detecting alarming changes at a very early stage, which means:

less invasive
and shorter treatment
faster recovery

* Prospective observational studies on a group of 1340 women conducted in reference centers for breast cancer diagnostics in Poland from 2009–2016.

Efficacy proven in observational studies

The Braster medical device was created in cooperation with Polish specialists from the best research centers. Thanks to their knowledge of, among other things, liquid crystal technologies, optoelectronics, and artificial intelligence, we were able to create a system that has the potential to become an important tool in breast cancer prophylaxis for women around the world. Together, we also conducted successful observational studies*.

* Observational studies conducted in Poland on a group of over 1500 women from 2013–2016.

Braster holds TUV NORD certificates in quality management systems, the main advantages of which are improvement of quality and services and a reduced risk of complaints.

The Braster System is a medical product meeting the requirements of the Council Directive 93/42/EEC (CE marking).

Learn more

Research centers cooperating with the Braster company

2 WARSAW

Saska Kepa Medical Center

ul. Marokanska 16, 03-977 (ThermaMED and Innomed)
Magodent

ul. Fieldorfa 40, 01-999 (ThermaMED)

1 WROCLAW

Lower Silesian Center of Oncology

pl. Hirszfelda 16, 53-416 (ThermaALG, ThermaMED and Innomed)

1 KATOWICE

Femina Medical Center

ul. Kłodnicka 23, 40-703 (ThermaMED)

3 KRAKOW

Specialist Medical Center for Minimally Invasive Surgery SCM Sp. z o.o.

ul. Grzegorzecka 67c/U6, 31-559 (ThermaALG)
Independent Public Health Care Center University Hospital (Collegium Medicum Jagiellonian University)

ul. Kopernika 36, 31-501
Zdrowie Kobiety Sp. z o.o.

ul. Praska 30 C, 30-328 (ThermaALG)

Key conclusions from the ThermaALG observational study:

The efficacy and usefulness of the Braster medical device for detecting pathologies in the mammary gland was confirmed
In women below 50 years of age, the sensitivity* of the method was 81.5% (95% CI: 64.1; 92.6), and its specificity** was 87% (95% CI: 79.7; 92.4)
The Braster medical device had 82% efficacy in detecting changes smaller than 2 cm
No impact of breast size or structure on efficacy of detecting lesions in the entire population of the examined women was found
The safety and non-invasiveness of the method were confirmed

* The likelihood of obtaining a positive result of the diagnostic test among ill patients. Higher sensitivity = overlooking fewer ill patients.

** The likelihood of obtaining a negative result of the diagnostic test among patients not suffering from the diagnosed disease. Higher specificity = fewer healthy patients incorrectly identified as ill.

Learn more

Opinion on usefulness of a medical device “BRASTER System of Home Prophylaxis of Breast Cancer”

Experts of the Polish Society of Gynecologists and Obstetricians recognized the method of contact thermography, used in the Braster examinations, as a complementary examination in relation to such tests as mammography or ultrasound.

See the opinion

8 experts in oncology, radiology, thermography, and optoelectronics with close links to BRASTER

MD, PHD

ANNA JUNG

Specialist in pediatrics, nephrology, and allergology. Founder and President of the Polish Society of Medical Thermography.

MD, PHD

ANDRZEJ KUŁAKOWSKI

Surgical oncologist, former Director of the Maria Skłodowska-Curie Memorial Cancer Center in Warsaw, and President of the Organisation of European Cancer Institutes.

MD, PHD

TADEUSZ PIEŃKOWSKI

Specialist physician in internal medicine, chemotherapist, and clinical oncologist.

MD, PHD

DARIUSZ ŚLADOWSKI

Specialist in tissue banking and regeneration medicine. Department of Transplantology and Central Tissue Bank, Medical University of Warsaw.

MD, PHD

ZBIGNIEW NOWECKI

Specialist in general surgery and surgical oncology, Head of the Department of Breast Cancer and Reconstructive Surgery at the Maria Skłodowska Curie Memorial Cancer Centre – Institute of Oncology, Voivodeship Consultant for Oncologic Surgery.

MD, PHD

ANDRZEJ CIESZANOWSKI

Specialist physician in radiology and Head of the Department of Diagnostic Imaging at the Maria Sklodowska-Curie Memorial Cancer Center – Institute of Oncology.

PHD, ENG

JÓZEF ŻMIJA

Employee of the Institute of Optoelectronics at the Military University of Technology. Doctor honoris causa of the Łódź University of Technology and honorary member of the Polish Liquid Crystal Society.

MD, PHD

JANUSZ ŻUBER

Specialist in internal medicine and infectious diseases at the Military Institute of Medicine in the Thermal Imaging Unit of the Department of Pediatrics, Pediatric Nephrology and Allergology.

Sign In

Create New Account

Forgot Password

Efficacy provenin observational studies*